These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26872624)

  • 1. Augmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatment.
    Safwat S; Hathout RM; Ishak RA; Mortada ND
    J Liposome Res; 2017 Mar; 27(1):1-10. PubMed ID: 26872624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
    Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells.
    Porfire A; Tomuta I; Muntean D; Luca L; Licarete E; Alupei MC; Achim M; Vlase L; Banciu M
    J Liposome Res; 2015; 25(4):261-9. PubMed ID: 25487170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells.
    Alayoubi AY; Anderson JF; Satyanarayanajois SD; Sylvester PW; Nazzal S
    Eur J Pharm Sci; 2013 Feb; 48(3):385-92. PubMed ID: 23262057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
    Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
    J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
    [No Abstract]   [Full Text] [Related]  

  • 6. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
    Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
    J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated lipid nanocapsules with improved drug encapsulation and controlled release properties.
    Hervella P; Alonso-Sande M; Ledo F; Lucero ML; Alonso MJ; Garcia-Fuentes M
    Curr Top Med Chem; 2014; 14(9):1115-23. PubMed ID: 24678710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
    Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
    Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromelain-Functionalized Multiple-Wall Lipid-Core Nanocapsules: Formulation, Chemical Structure and Antiproliferative Effect Against Human Breast Cancer Cells (MCF-7).
    Oliveira CP; Prado WA; Lavayen V; Büttenbender SL; Beckenkamp A; Martins BS; Lüdtke DS; Campo LF; Rodembusch FS; Buffon A; Pessoa A; Guterres SS; Pohlmann AR
    Pharm Res; 2017 Feb; 34(2):438-452. PubMed ID: 27981451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
    Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
    Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the templating approach in influencing the suitability of polymeric nanocapsules for drug delivery: LbL vs SC/MS.
    Goethals EC; Shukla R; Mistry V; Bhargava SK; Bansal V
    Langmuir; 2013 Oct; 29(39):12212-9. PubMed ID: 23998648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S; Ishak RAH; Hathout RM; Mortada ND
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.
    Ding B; Chen P; Kong Y; Zhai Y; Pang X; Dou J; Zhai G
    J Drug Target; 2014 Jan; 22(1):67-75. PubMed ID: 24099639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
    Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
    Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
    Tran TH; Nguyen TD; Poudel BK; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    AAPS PharmSciTech; 2015 Dec; 16(6):1307-16. PubMed ID: 25787869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Based Aqueous Core Nanocapsules (ACNs) for Encapsulating Hydrophillic Vinorelbine Bitartrate: Preparation, Optimization, Characterization and In vitro Safety Assessment for Intravenous Administration.
    Lakshmi ; Singh S; Vijayakumar MR; Dewangan HK
    Curr Drug Deliv; 2018; 15(9):1284-1293. PubMed ID: 30009708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the
    El-Sheridy NA; El-Moslemany RM; Ramadan AA; Helmy MW; El-Khordagui LK
    Drug Deliv; 2021 Dec; 28(1):906-919. PubMed ID: 33960245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.
    Yang Z; Luo X; Zhang X; Liu J; Jiang Q
    Biomed Mater; 2013 Apr; 8(2):025012. PubMed ID: 23507576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
    Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.